GlassScriptPhysician profile
Emily Brooke Combs
NPI 1235748880
$5,598.87
in general payments reported to CMS, 2019-2025
19 companies · $2,549 in 2025
The $2,549 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $175 · 2022: $254 · 2023: $1,620 · 2024: $1,001 · 2025: $2,549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,018 · Travel and Lodging: $2,098 · Education: $54.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,018.21 |
| Travel and Lodging | $2,097.85 |
| Education | $54.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,901.66 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $1,522.47 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Abbvie INC. | $384.04 | 2022-2025 | |
| Globus Medical, INC. | $245.79 | 2025 | Senza, Omnia |
| Inspire Medical Systems, INC. | $115.29 | 2023 | Inspire |
| Astrazeneca Pharmaceuticals LP | $102.56 | 2021-2024 | Tezspire |
| Abbott Laboratories | $84.98 | 2022-2024 | Proclaim |
| Xeris Pharmaceuticals, INC. | $34.33 | 2021 | |
| Lilly USA, LLC | $32.90 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.77 | 2022 | |
| Depuy Synthes Sales INC. | $22.31 | 2023 | Monovisc |
| Biohaven Pharmaceutical Holding Company LTD. | $21.64 | 2022 | |
| Inari Medical, INC. | $18.02 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Curonix LLC | $16.78 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertex Pharmaceuticals Incorporated | $16.25 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $15.77 | 2021 | |
| International Rehabilitative Sciences, INC | $13.33 | 2024 | Rs 4i Plus Sequential Stimulator |
| Novartis Pharmaceuticals Corporation | $13.29 | 2022 | |
| Merck Sharp & Dohme LLC | $12.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Combs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.